VT
Vyne Therapeutics Inc
🇺🇸XNAS.VYNEUnited StatesHealthcare
$25.50USDdown -0.76 (-2.89%)OpenEnd of day6:07 PM
Price$25.50-0.76 (-2.89%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US92941V2097
- CUSIP
- 92941V209
Company
- Employees
- 10
- Headquarters
- Stewartsville, United States
- Website
- https://vynetherapeutics.com
- CEO
- Mr. David T. Domzalski
Market
- Shares outstanding
- 667.7K
- Market cap
- $17.03M
Highlights
- Market cap
- $17.03M
- EPS LTM
- -$63.18calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.40calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $955K+100.63%up year on year
- Net income
- -$42.19M-9.44%down year on year
- Gross margin
- 97.59%+0.99%up year on year
- Free cash flow
- -$16.93M+57.55%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.